SCD Pre-Infusion Data

The Sickle Cell Disease (SCD) Pre-Infusion Data Form (Form 2030) is one of the Comprehensive Report Forms. This form captures SCD-specific pre-infusion data such as: disease classification at diagnosis, transfusion status prior to the start of the preparative regimen, organ assessments prior to the start of the preparative regimen, and the indication for transplant.

This form must be completed for all recipients randomized to the Comprehensive Report Form (CRF) track whose primary disease is reported on the Pre-TED Disease Classification Form (Form 2402) as Sickle Cell Disease (SCD).

Links to Sections of the Form

Q1: Subsequent Infusion
Q2 – 5: Sickle Cell Diagnosis
Q6 – 16: Transfusion Therapy
Q17 – 19: Therapy for Iron Overload
Q20 – 24: Pulmonary Assessments
Q25 – 34: Cardiovascular Assessments
Q35 – 40: Renal Assessments
Q41 – 45: Splenic Assessments
Q46 – 50: Acute Chest Syndrome
Q51 – 53: Pain
Q54 – 56: Avascular Necrosis
Q57 – 65: Central Nervous System
Q66 – 76: Other Symptoms
Q77 – 87: Existing Organ Impairments
Q88 – 94: Disease Modifying Therapies
Q95 – 118: Other Laboratory Studies
Q119 – 120: Reason for Infusion
Q121: Marrow Evaluation at Last Evaluation

Manual Updates:
Sections of the Forms Instruction Manual are frequently updated. The most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.

If you need to reference the historical Manual Change History for this form, please click here or reference the retired manual section on the Retired Forms Manuals webpage.

Date Manual Section Add/Remove/Modify Description
10/25/2024 2030 SCD Pre-Infusion Add Version 2 of the 2030: Sickle Cell Disease (SCD) Pre-Infusion section of the Forms Instructions Manual released. Version 2 corresponds to revision 4 of the Form 2030.
Last modified: Jan 27, 2025

Need more help with this?
Don’t hesitate to contact us here.

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.